Join to view full profile
UM Sylvester in Aventura2801 NE 213th stAventura, FL 33180
Phone+1 305-689-6500
Fax+1 305-689-6565
Dr. Krill-Jackson is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Elisa Krill-Jackson is a medical oncologist based in Miami, Florida, with a subspecialty focus on breast cancer. She completed her fellowship in Hematology and Medical Oncology at University of Miami/Jackson Health System and Tufts Medical Center and her residency in Internal Medicine at Brigham and Women's Hospital. She is a graduate of the University of Michigan Medical School. Dr. Krill Jackson is a specialist in breast oncology. She has been part of clinical trials on breast cancer treatment.
Education & Training
University of Miami/Jackson Health SystemFellowship, Hematology and Medical Oncology, 1994 - 1996
Tufts Medical CenterFellowship, Hematology and Medical Oncology, 1993 - 1994
Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 1990 - 1993
University of Michigan Medical SchoolClass of 1990
Certifications & Licensure
FL State Medical License 1994 - 2028
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2014, 2016-2017
Clinical Trials
Publications & Presentations
PubMed
- 6 citationsA Phase II Randomized Study of Paclitaxel Alone or Combined with Pelareorep with or without Avelumab in Metastatic Hormone Receptor-Positive Breast Cancer: The BRACELE...Amy S Clark, Fengmin Zhao, Paula Klein, Alberto J Montero, Carla Falkson
Clinical Cancer Research. 2025-07-01 - 3 citationsLong-term survival of women with locally advanced breast cancer with ≥ 10 involved lymph nodes at diagnosis.Simon B. Zeichner, Ludimila Cavalcante, Gabriel P. Suciu, Ana L. Ruiz, Alicia Hirzel
Asian Pacific Journal of Cancer Prevention. 2014-01-01 - 50 citationsThe spectrum of BRCA1 and BRCA2 mutations in breast cancer patients in the Bahamas.Mohammad R. Akbari, T Donenberg, J. Lunn, D. Curling, T. Turnquest
Clinical Genetics. 2014-01-01
Press Mentions
New Insights in Cancer Care Shared at Annual Oncology Update 2024October 30th, 2024
Breakthrough Treatment Helps Cancer Patients Keep Hair During ChemoOctober 28th, 2017
Professional Memberships
- Member
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
